Influenza vaccine (Dalian Hissen BioPharm)

流感病毒裂解疫苗（艾美汉信生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza vaccine (Dalian Hissen BioPharm)
Drug Alias NameN/A
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2012/11/22
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAimei Hissen Vaccine(Dalian) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAimei Hissen Vaccine(Dalian) Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksWikipediaKEGG